Molecular Markers in Acute Myeloid Leukemia (AML)
(Sprache: Englisch)
Acute myeloid leukemia is a malignant disease of the hematopetic system. It often leads to a massive proliferation of precoursors of myelopoiesis in the bone marrow and blood. Based on the morphology of the immature blood cells and their differentiation...
Leider schon ausverkauft
versandkostenfrei
Buch
28.90 €
14 DeutschlandCard Punkte
sammeln
- Lastschrift, Kreditkarte, Paypal, Rechnung
- Kostenlose Rücksendung
Produktdetails
Produktinformationen zu „Molecular Markers in Acute Myeloid Leukemia (AML) “
Klappentext zu „Molecular Markers in Acute Myeloid Leukemia (AML) “
Acute myeloid leukemia is a malignant disease of the hematopetic system. It often leads to a massive proliferation of precoursors of myelopoiesis in the bone marrow and blood. Based on the morphology of the immature blood cells and their differentiation AMLs are stratificated into eight sub-goups using the French-American-British classification (FAB). Despite classification, generating a prognosis for the patient is often difficult, which in turn makes the selection of the appropriate treatment more difficult. Prognosis is mainly based upon age, white-cell count and on cytogenetics of patients. The cytogenetic classification into the risk groups favorable, intermediate and unfavorable determines the intensity of therapy. In the intermediate group most patients have a normal karyotype, but their progress of disease is very variable. For this reason it is intended to search for novel prognostic, molecular markers which give a more accurate prediction of the progression of disease.
Bibliographische Angaben
- Autor: Iris Pöll
- 2016, 84 Seiten, Maße: 22 cm, Kartoniert (TB), Englisch
- Verlag: AV Akademikerverlag
- ISBN-10: 3330505427
- ISBN-13: 9783330505421
Sprache:
Englisch
Kommentar zu "Molecular Markers in Acute Myeloid Leukemia (AML)"
0 Gebrauchte Artikel zu „Molecular Markers in Acute Myeloid Leukemia (AML)“
| Zustand | Preis | Porto | Zahlung | Verkäufer | Rating |
|---|
Schreiben Sie einen Kommentar zu "Molecular Markers in Acute Myeloid Leukemia (AML)".
Kommentar verfassen